American Association for the Advancement of Science, Science Translational Medicine, 564(12), 2020
DOI: 10.1126/scitranslmed.aay4799
Full text: Unavailable
Intestinal CD146 + CCR5 + T cells activated by ICOSL + plasmacytoid DCs during acute GVHD can be inhibited by a dual ICOS/CD28 antagonist.